Powder: -20°C for 3 years
In solvent: -80°C for 2 years
TUG-770 is a highly potent agonist of free fatty acid receptor 1 (FFA1/<a href="/target/GPR" style="display: inline; color: #c13a36">GPR</a>40, EC50: 6 nM for hFFA1).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
50 mg | Inquiry | $ 1,000.00 | |
100 mg | Inquiry | $ 1,669.00 |
Description | TUG-770 is a highly potent agonist of free fatty acid receptor 1 (FFA1/GPR40, EC50: 6 nM for hFFA1). |
Targets&IC50 | hFFA1:6 nM (EC50) |
In vitro | TUG-770 (Compound 22) displayed excellent physicochemical and in vitro ADME properties, with good aqueous solubility, good chemical stability, low lipophilicity, and decreased plasma protein binding (PPB). TUG-770 furthermore showed excellent stability toward human liver microsomes, no inhibition of selected CYP-enzymes implicated in drug-drug interactions, no P-glycoprotein inhibition, and good permeability in the Caco-2 cell assay. |
In vivo | Examination of TUG-770 in an acute intraperitoneal glucose tolerance test (IPGTT) in normal mice revealed a good dose-dependent response with maximal reduction in glucose level reached at 50 mg/kg. The effect of TUG-770 was fully sustained after 29 days of daily oral treatment. Additional evaluation of TUG-770 in rats confirmed a significant glucose-lowering effect for the high doses already after 10 min and for all doses after 30 min. |
Molecular Weight | 307.32 |
Formula | C19H14FNO2 |
CAS No. | 1402601-82-4 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
H2O: Insoluble
DMSO: 100 mg/mL (325.39 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
TUG-770 1402601-82-4 GPCR/G Protein Endocrinology/Hormones GPR TUG770 TUG 770 Inhibitor inhibitor inhibit